Jean Leandro Dos Santos Selected Research

Jean Leandro Dos Santos Research Topics

11	Sickle Cell Anemia (Hemoglobin S Disease) 11/2022 - 04/2011
4	Neoplasms (Cancer) 01/2021 - 11/2016
3	Tuberculosis (Tuberculoses) 02/2024 - 11/2016
3	Chagas Disease (American Trypanosomiasis) 05/2022 - 07/2018
3	Malaria 01/2019 - 01/2014
2	Extensively Drug-Resistant Tuberculosis 01/2024 - 01/2022
2	Skin Neoplasms (Skin Cancer) 12/2019 - 05/2014
2	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2022
1	Inflammation (Inflammations) 10/2022
1	Cardiomyopathies (Cardiomyopathy) 05/2022
1	Megacolon 05/2022
1	Esophageal Achalasia (Megaesophagus) 05/2022
1	Priapism 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 10/2019
1	Multiple Myeloma 10/2019
1	Leishmaniasis 01/2019
1	African Trypanosomiasis (Nagana) 01/2019
1	Neglected Diseases 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2017
1	Infections 10/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2014
1	Vivax Malaria 01/2014

5	ResveratrolIBA 05/2022 - 11/2016
3	Fetal Hemoglobin (Hemoglobin F)IBA 10/2022 - 01/2018
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022 - 09/2012
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2018 - 04/2011
2	ProdrugsIBA 11/2023 - 01/2014
2	GlobinsIBA 11/2022 - 01/2021
2	NitratesIBA 10/2022 - 04/2011
2	CurcuminIBA 05/2022 - 11/2016
2	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2020
2	AntioxidantsIBA 12/2019 - 05/2014
2	OxidesIBA 06/2018 - 01/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2024
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2024
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2022
1	Nitric Oxide DonorsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	pomalidomideIBA 01/2021
1	CarcinogensIBA 01/2020
1	gamma-GlobinsIBA 01/2020
1	Sunscreening Agents (Sunscreens)IBA 12/2019
1	Boronic AcidsIBA 10/2019
1	tavaboroleIBA 10/2019
1	crisaboroleIBA 10/2019
1	Bortezomib (Velcade)FDA Link 10/2019
1	BoronIBA 10/2019
1	DipeptidesIBA 10/2019
1	SemicarbazonesIBA 01/2019
1	ThiosemicarbazonesIBA 01/2019
1	ThiazolesIBA 01/2019
1	NifurtimoxIBA 07/2018
1	benzonidazole (benznidazole)IBA 07/2018
1	Cyclic N-Oxides (Oxides, Cyclic N)IBA 01/2018
1	Therapeutic UsesIBA 11/2017
1	PolyphenolsIBA 11/2016
1	1,2,5-oxadiazole 2-oxideIBA 11/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2015
1	Proton Pump InhibitorsIBA 10/2015
1	EnzymesIBA 01/2014
1	Chloroquine (Aralen)FDA LinkGeneric 01/2014
1	Primaquine FDA Link 01/2014
1	Phe-Ala-PQIBA 01/2014
1	phthalimideIBA 09/2012
1	BenzenesulfonamidesIBA 04/2011
1	ethyl nitrateIBA 04/2011
1	methyl nitrateIBA 04/2011

7	Therapeutics 02/2024 - 01/2018
1	Art Therapy 11/2023